Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases

MLA

Oksbjerg, N. R., et al. “Anti-CD20 Antibody Therapy and Risk of Infection in Patients with Demyelinating Diseases.” Oksbjerg , N R , Nielsen , S D , Blinkenberg , M , Magyari , M & Sellebjerg , F 2021 , ’ Anti-CD20 Antibody Therapy and Risk of Infection in Patients with Demyelinating Diseases ’ , Multiple Sclerosis and Related Disorders , Vol. 52 , 102988 , 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322760999&authtype=sso&custid=ns315887.

APA

Oksbjerg, N. R., Nielsen, S. D., Blinkenberg, M., Magyari, M., & Sellebjerg, F. (2021). Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases. Oksbjerg , N R , Nielsen , S D , Blinkenberg , M , Magyari , M & Sellebjerg , F 2021 , ’ Anti-CD20 Antibody Therapy and Risk of Infection in Patients with Demyelinating Diseases ’ , Multiple Sclerosis and Related Disorders , Vol. 52 , 102988 .

Chicago

Oksbjerg, N. R., S. D. Nielsen, M. Blinkenberg, M. Magyari, and F. Sellebjerg. 2021. “Anti-CD20 Antibody Therapy and Risk of Infection in Patients with Demyelinating Diseases.” Oksbjerg , N R , Nielsen , S D , Blinkenberg , M , Magyari , M & Sellebjerg , F 2021 , ’ Anti-CD20 Antibody Therapy and Risk of Infection in Patients with Demyelinating Diseases ’ , Multiple Sclerosis and Related Disorders , Vol. 52 , 102988 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322760999&authtype=sso&custid=ns315887.